A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more ...

HOUSTON, Texas (KTRK) -- For almost 35 years, the Aplastic Anemia and MDS International Foundation has been working to provide education, support and hope for patients living with bone marrow failure ...

Centers for Medicare & Medicaid Services is considering expanding the national coverage determination for allogeneic hematopoietic stem cell transplants using bone marrow or peripheral blood stem cell ...

Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose – and are commonly misdiagnosed – putting patients at increased risk for treatment mistakes and other ...

Investigators say a better understanding of risk factors and categories can help personalize care for patients living with myelodysplastic syndrome (MDS). Men, patients with low absolute neutrophil ...

As Robin Roberts, co-anchor for ABC's "Good Morning America," prepares for her medical leave, a physician says Roberts's case shouldn't frighten women from continuing surveillance of their breast ...

The FDA recently approved Tibsovo for relapsed/refractory MDS with an IDH1 mutation, a treatment option for a disease subset with no options before this approval. The recent approval of Tibsovo ...

Smokers with myelodysplastic syndromes (MDS) or a precursor condition had elevated levels of genetic mutations linked to the disease, a new study shows. The study also found that heavier smokers ...

Fatigue is one of the most common symptoms in myelodysplastic syndromes (MDS), and severe fatigue has been linked with less favorable mortality outcomes. Low blood cell counts (cytopenias) can drive ...